Published by Global Banking & Finance Review®
Posted on December 17, 2025
1 min readLast updated: January 20, 2026
Add as preferred source on Google
Cinven's co-managing partner and CFO step down amid a UK pricing probe. The CMA upheld a £51.9 million penalty for excessive drug pricing.
Dec 17 (Reuters) - International private equity firm Cinven said on Wednesday co-managing partner Supraj Rajagopalan and chief financial officer Alex Leslie, who is also the chief operating officer, will step down from their roles and leave the firm.
Mike Colato, former CFO who currently serves as senior advisor, will take over as interim COO and CFO, the company said.
Rajagopalan's departure comes as UK regulators consider asking a court to ban him over alleged price-gouging by a drugmaker previously owned by Cinven, the Financial Times reported. He decided to leave due to uncertainty created by the competition watchdog's investigation, the report said citing people familiar with the matter.
In May, the Court of Appeal upheld the CMA's finding of excessive and unfair pricing in the supply of liothyronine tablets in the UK, reinstating a penalty of 51.9 million pounds ($69.49 million) on Cinven.
The company declined to comment on the reason for the management changes.
($1 = 0.7469 pounds)
(Reporting by Aatrayee Chatterjee in Bengaluru; Editing by Krishna Chandra Eluri)
A private equity firm is an investment management company that provides financial backing and makes investments in private companies, often through buyouts or venture capital.
A chief financial officer (CFO) is a senior executive responsible for managing the financial actions of a company, including financial planning, risk management, record-keeping, and financial reporting.
Price-gouging refers to the practice of raising prices on essential goods and services to an excessively high level during emergencies or shortages, often considered unethical or illegal.
Explore more articles in the Finance category
